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Abstract
Background: The UK, USA and the World Health Organization have identified improved patient
safety in healthcare as a priority. Medication error has been identified as one of the most frequent
forms of medical error and is associated with significant medical harm. Errors are the result of the
systems that produce them. In industrial settings, a range of systematic techniques have been
designed to reduce error and waste. The first stage of these processes is to map out the whole
system and its reliability at each stage. However, to date, studies of medication error and solutions
have concentrated on individual parts of the whole system. In this paper we wished to conduct a
systematic review of the literature, in order to map out the medication system with its associated
errors and failures in quality, to assess the strength of the evidence and to use approaches from
quality management to identify ways in which the system could be made safer.
Methods: We mapped out the medicines management system in primary care in the UK. We
conducted a systematic literature review in order to refine our map of the system and to establish
the quality of the research and reliability of the system.
Results: The map demonstrated that the proportion of errors in the management system for
medicines in primary care is very high. Several stages of the process had error rates of 50% or
more: repeat prescribing reviews, interface prescribing and communication and patient adherence.
When including the efficacy of the medicine in the system, the available evidence suggested that
only between 4% and 21% of patients achieved the optimum benefit from their medication. Whilst
there were some limitations in the evidence base, including the error rate measurement and the
sampling strategies employed, there was sufficient information to indicate the ways in which the
system could be improved, using management approaches. The first step to improving the overall
quality would be routine monitoring of adherence, clinical effectiveness and hospital admissions.
Conclusion: By adopting the whole system approach from a management perspective we have
found where failures in quality occur in medication use in primary care in the UK, and where
weaknesses occur in the associated evidence base. Quality management approaches have allowed
us to develop a coherent change and research agenda in order to tackle these, so far, fairly
intractable problems.
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Background
The UK, USA and the World Health Organization [1-4]
have identified that priority should be given to improved
patient safety in healthcare. Medication error has been
shown to be one of the most frequent forms of medical
error and it is associated with significant medical harm.
For example, in the UK, 4.5% - 5% of admissions to sec-
ondary care have resulted from preventable drug-related
morbidity: preventable harm from medicines could cost
more than £750 million pounds per year in England [5].
It is generally accepted that errors are the result of the sys-
tems that produce them [6]. To date, studies measuring
medication error have been limited as they have focused
on specific errors, such as prescribing or administration
errors, rather than on the whole system of the use of med-
icines. Consequently, solutions to medication errors have
concentrated on just one part of the whole system, such as
prescribing or dispensing errors. We have little idea how
these errors interact or whether problems at one part of
the system would have been significantly reduced by
intervention at another part of the system. An example
would be medicines reconciliation interventions, which
have been recommended as good practice in the UK [7]
and the USA [8].
Individual interventions, such as reconciliation, seek to
rectify errors which have occurred at just one point in the
medicines system. For example, the aim of medicine rec-
onciliation on admission to hospital is to ensure that
medicines prescribed on admission correspond to those
that the patient was taking before admission. It does this
by: collecting information on medication history; check-
ing or verifying this list against the current prescription
chart in the hospital; and documenting any changes,
omissions and discrepancies [7]. Some interventions have
reduced discrepancies in one part of the system, e.g. phar-
macist-led medicine reconciliation on admission [7].
However, further discrepancies may re-occur at a later
stage in the use of medicines. In addition, interventions
such as reconciliation seek to correct errors which have
already occurred rather than to improve the system in
order to prevent such errors from occurring. This piece-
meal approach to solutions may be one reason why a
recent meta analysis found no evidence for the effective-
ness of the majority of interventions aimed at reducing
preventable drug-related morbidity or admissions to hos-
pital [9]. There is little evidence that reductions in error
rates lead to improved health outcomes.
In industrial settings there is a range of systematic tech-
niques designed to improve the reliability of processes
and the reduction of waste. Some of these, such as lean
and six sigma, have been applied to healthcare [10-13]
and include medication errors in secondary care [14,15].
The first stage of these processes is to map the whole sys-
tem and establish the reliability of each stage. More than
80% of prescriptions for medication are written, and 71%
of the medication budget is currently spent, in primary
care [5]. We therefore chose to map out the use of medi-
cation in primary care in order to establish its quality and
reliability, using the UK as an exemplar. The UK is a uni-
fied healthcare system with a large number of prescrip-
tions. Our approach was to conduct a systematic review of
the literature, to map out the system and its associated
errors, to assess the strength of the evidence and to use
approaches from quality management to identify ways in
which the system could be made safer.
Methods
Systematic review
We carried out a systematic review of studies addressing
error rates in the management of medicines in primary
care searching the following databases: Medline, Embase;
International Pharmaceutical Abstracts; Pharmline;
Cinahl; Psycinfo; and the Kings Fund. Given the growth of
electronic prescribing in primary care in the UK, and the
rapid development of the medicines policy, we only
searched papers from 1996 onwards. We used the key-
words 'medication error', and 'primary healthcare', 'gen-
eral practice', 'family practice', 'patient discharge', 'patient
admission', 'medical records', 'continuity of patient care',
'hospital-physician-relations' or 'prescribing error.' We
also searched the reference lists of relevant papers in order
to identify any additional studies and contacted known
experts.
We included studies medicines which were carried out in
the UK and reported the frequency of errors in the man-
agement of medicines in primary care, the frequency of
prescribing errors in outpatient referrals or admissions to
secondary care (as these potentially affect medication pre-
scribed later in primary care). We included all definitions
of error. We excluded: studies relying on spontaneous
reports, as such studies grossly underestimate the error
rates [16]; studies which did not report the method used
for measuring error; studies of discrepancies on admission
to hospital which only compared medication histories of
different healthcare professionals in secondary care and
did not access general practitioner (GP) medication
records; and studies which only measured the error rate of
one medication or therapeutic group.
One reviewer screened all titles and abstracts in order to
determine whether the research paper met the inclusion
criteria and should therefore be retrieved; a second inde-
pendently screened a random 10% sample in order to
check the reliability of the screening (the agreement level
was 92%). The first reviewer then abstracted data from the
included articles. This included an assessment of the sam-BMC Medicine 2009, 7:50 http://www.biomedcentral.com/1741-7015/7/50
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pling strategies employed and the validity and reliability
of error rate measurement. The second reviewer inde-
pendently extracted data from a random 50% sample in
order to check the reliability of the data extraction (the
agreement level was 94%).
Mapping the system
We mapped out the process of medicine usage in primary
care and produced a high-level process map, in accord-
ance with established processes [17] using an iterative
process of refining the map in the light of findings from
the literature review. We included episodes of secondary
care which patients in primary care may have experienced
(as outpatients or inpatients), treating them as a 'black
box' rather than studying all types of errors that could
occur in these settings. We superimposed the error rates,
non-adherence rates and lack of efficacy rates, found in
the literature at each stage of the process, onto the map.
Where more than one study addressed the reliability of a
particular stage, we reported the range of rates found.
Meta analysis was not appropriate due to the heterogene-
ity of methodology (discussed later). For the purpose of
reviewing the system, non-adherence was treated as an
error, or a system failure, as the intended outcome was
treatment of the patient with a medicine. We recognize
that non-adherence in some cases could be seen as an
appropriate act taken by patients, however, although
unquantified, this did not seem to occur very often.
Unlike other forms of medication error, there is extensive
literature on non-adherence which has been summarized
in recent reviews [18,19]. We therefore used the adherence
rates reported by the National Institute for Clinical Excel-
lence (NICE) [18] and the Cochrane Collaboration [19],
rather than conducting our own review.
Failures in drug effectiveness were included in the model,
although these are not actual errors as they result in a loss
of patient benefit from medication and, therefore, a loss
in the quality of outcome. These failures were calculated
using the NNT (number needed to treat); i.e. for a drug
with NNT 2, two patients would be needed to be treated
for every one who gains the required health outcome. This
can be seen as a 50% failure rate in effectiveness.
A quality filter map [20] was produced in order to demon-
strate the cumulative loss of quality at each consecutive
stage of the medicine management process. The filter is
similar to a survival curve in which the abscissa is categor-
ical rather than continuous data. It was generated using
the findings from the literature for each stage of the proc-
ess to estimate the number who could be expected to be
seen for a single prescription with no secondary care inter-
face. There were some limitations to this part of the map-
ping process because units of measurement for error rates
have not been consistent (an issue explored later). How-
ever, it provided an illustration of the nature and extent of
quality problems in the system.
Results
Twenty-seven relevant papers were found which met the
inclusion criteria (see Figure 1). The methodological char-
acteristics of the included studies are shown in Additional
file 1. The whole system, including the frequency of errors,
is illustrated in Figure 2[21-47]. The quality filter (Figure
3) includes two exemplar NNTs from the range usually
funded in primary care, listing the most effective medi-
cines used (NNT of 2) to a value that is usually accepted
(10). We realize that NNTs may (depending on the design
of the contributing trials) reflect elements of non-adher-
ence. However, as trials are usually designed to improve
efficacy and minimize non-adherence, we did not expect
this to significantly affect the system for the purposes of
this paper.
Figure 2 demonstrates that: quality issues exist at every
stage of the process and that several stages of the process
had error rates of 50% or more which included repeat pre-
scribing reviews, interface prescribing and communica-
tion and patient adherence. Furthermore, it can be seen
from Figure 3 that the available evidence suggests that
only between 4% and 21% of patients achieve the opti-
mum benefit from their medicines.
Discussion
This is the first systematic review of the cumulative medi-
cation errors of a country's healthcare system, linked to a
discussion of the whole system. This approach allows the
development of a system-wide approach to the improve-
ment of quality in the use of medication. However, we rec-
ognize that there are limits to our methodology. We
merged different types of studies and some areas of the
map are more greatly populated than others. Weaknesses
of the map are a reflection of the primary data. In the next
section we reflect on the quality of the data which we
found, as it affects our understanding of the whole system
and also sets a research agenda of its own. We then discuss
approaches to creating improvement.
Limitations of research reviewed
The limitations fall into four groups: (1) a dearth of stud-
ies, (2) the method of identifying and measuring the
error, (3) the use of different units of measurement and
(4) sampling limitations.
There is a dearth of evidence relating to some parts of the
system, primarily related to prescribing. For example,
studies which have investigated the accuracy of general
practice medical records have focused on diagnosis rather
than medication records [48,49]. From Figure 1 it can be
seen how crucial the accuracy of the GP medicationBMC Medicine 2009, 7:50 http://www.biomedcentral.com/1741-7015/7/50
Page 4 of 8
(page number not for citation purposes)
records are to the whole system and that further research
in this area is urgently needed. In addition, research
addressing the rates of the reviews of repeat prescriptions
was conducted over 10 years ago and should now be
updated [28].
The methodology used to measure error has been prob-
lematic. Definitions of error have differed between studies
which makes comparisons difficult. Some studies may not
have been able to identify all the errors. For example,
Shah et al. [21] conducted a study in which prescriptions
were reviewed in pharmacies in order to determine the
prescribing error rate: this is unlikely to detect all of the
errors [41]. Difficulties have also arisen when attempts
have been made to determine the rates of errors in medi-
cation history taking when patients are admitted to hospi-
tal because there is no a gold standard with which to
compare the medication history as general practice
records have also been found to be inaccurate [30]. Dis-
crepancies rather than error rates have therefore been
reported. Studies have classified discrepancies as inten-
tional or unintentional when patients are issued repeat
prescriptions after being discharged from hospital. How-
ever, in three of the studies GPs were not interviewed in
order to check their intentions and therefore this classifi-
cation may have been inaccurate [36,45,46].
Flow chart of papers identified, screened and evaluated Figure 1
Flow chart of papers identified, screened and evaluated.
Number of articles 
retrieved from 
electronic search = 
1226
Number of articles 
after duplicates 
removed = 1129
Number of full 
articles evaluated 
= 117
Number of 
duplicates 
removed = 107
Number of articles 
excluded after title 
and abstract 
screening = 1008
Not uk = 888
Topic not relevant = 45
Does not report medication 
error rate= 44
Uses spontaneous report to 
measure error = 17
Limited to one medication or 
therapeutic group = 3
Only reports administrating 
or dispensing errors in 
secondary care = 8
Compares different hcp in 
secondary care without other 
source= 2
Publication out of print and  
unavailable=1
Number of articles 
excluded after 
evaluation = 90
Not uk = 23
Topic not relevant = 9
Does not report medication 
error rate= 44
Does not report detail of 
method of measuring error= 
5
Uses spontaneous report to 
measure error= 5
Only reports administrating 
or dispensing errors in 
secondary care = 2
Compares different hcp in 
secondary care without other 
source = 2
Number of articles 
included after 
evaluation = 27
Number of reviews 
identified = 22
Full articles 
scanned for 
primary studies
Number of hand 
searched articles  
added = 18BMC Medicine 2009, 7:50 http://www.biomedcentral.com/1741-7015/7/50
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It is also difficult to compare error rates across the medi-
cine management system as error rates have been meas-
ured using different units. Prescribing and dispensing
errors have been measured using the number of items as
the denominator in the majority of cases [21,24]. How-
ever, adherence has been measured per patient [18,19]
and satisfaction with discharge communication has been
measured per GP [32,33]. In future it may be best if error
rates were expressed using more than one criterion, such
as by act and by patient.
The limited sampling strategies employed in studies have
led to some of the data collected being unrepresentative.
Most studies conducted in the hospital setting have been
carried out at a single site, sampled for convenience
[25,27,29,37,39,40] and, in some cases, have been spe-
cific to a single patient group [29,37]. In addition, some
studies have been carried out at a single GP surgery
[21,22] or on a convenient sample of independent phar-
macies [24]. In some cases, there was no information
given about the sampling strategy [21,26,38] or the
patients within a practice have not been randomly sam-
pled [22]. Lack of contextual information has meant that
one cannot determine how representative the results have
been. In addition, in other areas, such as adherence and
preventable drug-related admissions, random sampling
has been employed or there have been consistent results
between studies leading to a cumulative validity.
Creating improvement
While we acknowledge the limitations of the literature,
there is still sufficient information to indicate the ways in
which the system could be made safer. There are several
management techniques which have been designed to
improve reliability and quality and to reduce waste - for
example 'lean' aims to reduce waste by removing non-
value added steps from a process and 'six sigma' aims to
reduce the variation in order to produce a uniform process
output. Given the opportunity for improvement based
upon quantifiable error rates over periods of time, the six
A map of the medicine related processes that affect the quality of medicine use in primary care Figure 2
A map of the medicine related processes that affect the quality of medicine use in primary care.
Patient sees GP
Patient is prescribed 
medication.  Prescribing 
decision is based on :
1) GP own information
2) Hospital 
recommendation
3) Patient symptoms/
requests
Prescription taken to 
pharmacy
Medication dispensed
Patient takes medication
Patient improves/stabilises
Patient requests repeat 
medication
Prescribing reviewed at 
least every 6
th request
Patient feels 
worse
Patient decides 
not to take 
medication.  
(remove from 
system)
GP Prescribing error rate 7.46% items[21]:
No directions 25%
Prescribing something not needed 18%
Directions incomplete 11%
Over supply 11%
Strength missing 9%
Quantity missing 8%
No Signature 5%
Other 13%
2.9% prescriptions[22] –
5.2% items[23] not ‘cashed’ 
at pharmacy
Dispensing error rate 3.3% 
items[24}
1.6% labelling errors
1.7% content errors
Clinical Severity:
67: minor
32% moderate
1% severe
Patient non-adherence = 30-
50% patients[18-19]
Medication ineffective = 10-
50% (NNT medication 2-10)
Drug related admissions = 
6.5%-7.5% admissions[25-
27]
69% of these are 
preventable
Medication not reviewed in 
15 months = 72% [28]
GP refers to 
hospital
outpatients
Scheduled or 
unscheduled GP 
admission
Recommendation 
made to GP
Medication 
assimilated into 
patient record at 
GP Practice
Medication being taken not on 
GP record = 5% items[30]
Dosage not on record = 13% 
consultations[31]
Emergency 
admission
Existing 
medication 
established and 
prescribed
Medication 
reviewed.  Existing 
removed.  New 
added
Medication 
reviewed based 
on clinical 
progress
Some/all/other 
medication 
selected for 
discharge 
Discharge 
medication 
dispensed and 
given to patient
Unintentional 
discrepancies in 
medication 
prescribed on 
admission = 58-
62% patients[34-
35]69-70% 
items[36-37]
In patient 
prescribing error 
error rate = 2.9-
18.7% items [38-
43] 14% patients
[44] 
Discharge 
medication 
communicated to 
GP
58-67%  of GPs not satisfied 
with information received 
from the hospital on patients’ 
discharge therapy[32-33] 
Unintentional 
discrepancies in 
discharge 
medication 
received by 
patients = 11%-
27% items [38,45].  
Unintentional 
discrepancies in 
repeat medication 
subsequently 
received from GP = 
43-60% items [36-
37,45-46],  57% 
patients [47] 
Outpatient error rate = 77.4%
items [29]BMC Medicine 2009, 7:50 http://www.biomedcentral.com/1741-7015/7/50
Page 6 of 8
(page number not for citation purposes)
sigma approach to structured improvement is especially
relevant to the improvement of quality of medication use.
This approach uses a systematic methodology to define,
measure, analyse, improve and control the situation. Such
techniques have been successfully applied to healthcare
[10-13], including the reduction of medication error in
secondary care [14,15]. However, there is little evidence of
the successful application of these management strategies
to the primary healthcare setting generally, or to the
improvement in quality of medication use in primary
care. Natarjan [50] has identified a number of barriers for
the application of improvement tools to primary care set-
tings. They include: lack of awareness that problems exist;
poor understanding of systems thinking; a traditional
medical culture of individual responsibility; legal issues
encouraging the concealment of error; poor information
technology provision; poor data; and resource issues. In
addition, unlike the situation seen in secondary care,
patients have complete freedom of action and the health-
care may professionals come from several different organ-
izations. Any solution must be able to address these
challenges.
A systematic approach, based on the existing evidence, is
required in order to identify how we should apply man-
agement strategies to the improvement of the quality of
medication use in primary care. The approach requires a
method of identifying priorities, a systematic measure-
ment of error and the systematic design and testing of
solutions. As problems of maintaining quality occur at
every stage of the medicine management system in pri-
mary care, there is a need to prioritize the processes which
need to be improved. We need to examine the impact of
errors on the system as a whole and use that knowledge to
develop an approach which will maximize its value to
patients.
One method of choosing which processes need to be
improved is to identify those that have both high error
rates and which cause high levels of harm [51]. Figure 1
shows the processes with the highest error rates. However,
as data regarding harm is not available for all of the proc-
esses, this method is inappropriate. A more promising
method would be to prioritize processes at the patient end
of the system and gradually work backwards, thereby
maximizing value to the patient [17]. The aim of the sys-
tem is to ensure that patients are taking medication suc-
cessfully and that the medication is effective and not
harmful. Improving these processes would be expected to
lead to improvements in patient care. Medication adher-
ence, effectiveness and lack of harm are therefore the
stages on which we first should focus. These are the proc-
esses which are most important to the patient and in
which there is high loss of quality. In order to improve
these processes, we also a need to consider feedback loops
within the system, another area in which there has been
insufficient research. For example, it may not be possible
to improve the NNT of a medication but effective feed-
back systems, such as medication reviews and monitoring,
may allow prescribers and others to change ineffective or
harmful medication and improve the quality of outcome.
Having identified the areas which should be given prior-
ity, the next stage is to measure and standardize processes
at a local level. In order to assess the effects of the inter-
ventions, we need to establish standard methods for
measuring system errors so that error rates can be moni-
tored and compared. Statistical process monitoring is a
management technique which can assist this process. It
uses control charts to monitor processes [52], allowing
the measurement of changes in, and the predictability of,
the mean error rate. It is necessary to know the predicta-
bility of error as management strategies cannot be applied
to the reduction of error if the rates are unpredictable or
chaotic; it is essential that error rates first be stabilized and
that the adherence rates and clinical effects have been
monitored as proxies for the desired clinical outcome.
Adherence would probably need to be measured by tech-
niques such as self report and dispensing records. The
measurement of clinical effectiveness would depend on
the drug being used, the condition being treated and
number of admissions to hospital.
Once data has been collected, the analyses will indicate
which solutions would be appropriate. If error rates are
chaotic, the first stage would be to reduce variation. Con-
trol charts can identify whether the variations have a com-
mon or a specific cause. In order to reduce common
Quality filter map Figure 3
Quality filter map.
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causes of the variations we must improve the process, but
to reduce specific causes we need to identify and act on
factors which are extrinsic to the process [52]. Once the
process is stable, root cause analysis can be used as a tool
to identify the causes of error. Once this knowledge is
gained, appropriate solutions for reducing error rates can
be identified and evaluated. It should be possible to
extrapolate the information from representative and
reproducible data collected at local levels and apply it at a
national level.
Conclusion
By adopting the whole system approach from a manage-
ment perspective we have discovered where the failures in
quality occur in medication use in primary care in the UK,
and where weaknesses lie in the associated evidence base.
Quality management approaches allow for the prioritiza-
tion of research and the coherent change and research
agenda needed to tackle these, so far, fairly intractable
problems.
Abbreviations
GP: General practitioner; NNT: number needed to treat.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SG conducted the literature search and was involved in
writing the paper. NB was involved in the design and writ-
ing of the paper. PW evaluated alternative approaches to
the analysis and was involved in the development of the
maps. AW secured funding, established the research team
and was involved in the conceptualization, design and
editing of the paper. LE acted as a second reviewer in order
to establish the reliability of the review process. All
authors have seen and approved the final version.
Additional material
Acknowledgements
Funding was provided by the National Leadership and Innovation for 
Healthcare, NHS Wales.
References
1. Department of Health: An organisation with a memory. Report of an
expert group on learning from adverse events in the NHS London: The
Stationery Office; 2000. 
2. Department of Health: Building a safer NHS for patients: improving med-
ication safety. A report by the Chief Pharmaceutical Officer London: The
Stationery Office; 2004. 
3. Institute of Medicine: To err is human: Building a safer health system.
Report of the Committee on Quality of Healthcare in America Washington:
National Academy Press; 2000. 
4. World Health Organization: Quality of care: patient safety. Report by the
Secretariat Geneva: World Health Organization; 2002. 
5. Department of Health: Pharmacy in England. Building on strengths-deliv-
ering the future London: The Stationary Office; 2008. 
6. Department of Health: Design for safety. A system-wide design-led
approach to tackling patient safety in the NHS London: Department of
Health; 2003. 
7. National Institute of Clinical Excellence: Technical patient safety solu-
tions for medicines reconciliation on admission of adults to hospital: Guid-
ance London: NICE; 2007. 
8. Institute of Healthcare Improvement: Getting started kit: Prevent
adverse drug events (medication reconciliation). How-to guide Massachu-
setts: Institute of Healthcare Improvement; 2007. 
9. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A: Interventions
in primary care to reduce medication related adverse events
and hospital admissions: systematic review and meta-analy-
sis.  Qual Safe Health Care 2006, 15:23-31.
10. Spear S: Fixing healthcare from the inside.  Harvard Business Rev
2005, 83:78-91.
11. Berwick DM, Godfrey AB, Roessner J: Ten key lessons for quality
improvement during healthcare.  In New strategies for Quality
improvement San Francisco: Jossey-bass; 1990:157. 
12. Proudlove N, Moxham C, Boaden R: Lessons for Lean in Health-
care from Using Six Sigma in the NHS .  Public Money Manage-
ment 2008, 28(1):27-34.
13. Taner MT, Sezen B, Antony J: An overview of six sigma applica-
tions in healthcare industry.  Int J Health Care Qual Assur 2007,
20:329-340.
14. Esimai : Lean Six Sigma reduces medication errors.  Quality
Progress 2005, 38:51-57.
15. Al-Shaqha WMS, Zairi M: Reengineering pharmaceutical care:
towards a patient-focused care approach.  Int J Health Care Qual
Assur 2000, 13:208-217.
16. Franklin BD, O'Grady K, Paschalides C, Uley M, Gallavin S, Jacklin A,
Barber N: Providing feedback to hospital doctors about pre-
scribing errors: a pilot study.  Pharm World Sci 2007, 29:213-220.
17. Rother M, Shook J: Learning to see: value-stream mapping to create value
and eliminate muda Massachusetts: The Lean Enterprise Institution;
2003. 
18. National Collaborating Centre for Primary Care: Medicines adherence
Involving patients in decisions about prescribed medicines and supporting
adherence London National Institute for Health and Clinical Excel-
lence; 2009. 
19. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interven-
tions for enhancing medication adherence.  Cochrane Database
of Systematic Reviews 2008:CD000011.
20. Bicheno J: The New Lean Toolbox Buckingham: PICSIE Books; 2004. 
21. Shah SNH, Aslam M, Avery AJ: A survey of prescription errors in
general practice.  Pharmaceutical J 2001, 267:860-862.
22. Jones I, Britten N: Why do some patients not cash their pre-
scriptions?  Br J Gen Pract 1998, 48:903-905.
23. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, Mac-
Donald TM: Primary non-compliance with prescribed medica-
tion in primary care.  Br Med J 1993, 307:846-848.
24. Dean Franklin B, O'Grady K: Dispensing errors in community
pharmacy: frequency, clinical significance and potential
impact of authentication at the point of dispensing.  Int J Phar-
macy Practice 2007, 15:273-281.
25. Howard RL, Avery AJ, Howard PD, Partridge M: Investigation into
the reasons for preventable drug related admissions to a
medical admissions unit: observational study.  Qual Safe Health
Care 2003, 12:280-285.
26. Pirohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Far-
rar K, Park BK, Breckenridge AM: Adverse drug reactions as
cause of admission to hospital: prospective analysis of 18 820
patients.  Br Med J 2004, 329:15-19.
27. Green CF, Mottram DR, Rowe PH, Pirmohamed M: Adverse drug
reactions as a cause of admission to an acute medical unit: a
pilot study.  J Clin Pharm Ther 25:355-361.
Additional file 1
Table S1. Studies included.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-
7015-7-50-S1.RTF]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medicine 2009, 7:50 http://www.biomedcentral.com/1741-7015/7/50
Page 8 of 8
(page number not for citation purposes)
28. Zermansky AG: Who controls repeats.  Br J Gen Pract 1996,
46:643-647.
29. Jani YH, Ghaleb MA, Marks SD, Cope J, Barber N, Wong ICK: Elec-
tronic prescribing reduced prescribing errors in a pediatric
renal outpatient clinic.  J Pediat 2008, 152:214-218.
30. Collins DJ, Nickless GD, Green CF: Medication histories; does
anyone know what medicines a patient should be taking?  Int
J Pharmacy Practice 2004, 12:173-178.
31. Hippisley-Cox JH, Pringle M, Cater R, Wynn A, Hammersley V, Cou-
pland C, Hapgood R, Horsfield P, Teasdale S, Johnson C: The elec-
tronic patient record in primary care- regression or
progression? A cross sectional study.  Br Med J 2003,
236:1439-1443.
32. Manday A, Kelly B, Forrester JWE, Timoney A, McGovern E: Do gen-
eral practitioners and community pharmacists want infor-
mation on the reasons for drug therapy changes
implemented by secondary care?  Br J Gen Pract 1997,
47:563-566.
33. Brookes K, Scott MG, McConnell JB: The benefits of a hospital
based community services liason pharmacy.  Pharm World Sci
2000, 22:33-38.
34. Ahmed S, Harding J: Investigating the procedures, drawbacks
and implications of seamless primary-secondary care.  Quality
in Primary Care 2005, 12:51-55.
35. Rees S, Thomas P, Shetty A, Makinde K: Drug history errors in the
acute medical assessment unit quantified by the use of the
NPSA classification.  Pharmaceutical J 2007, 279:469-471.
36. Pickrell L, Duggan C, Dhillon S: From hospital admission to dis-
charge: an exploratory study to evaluate seamless care.  Phar-
maceutical J 2001, 267:650-653.
37. Morcos S, Francis S-A, Duggan C: Where are the weakest links?
A descriptive study of discrepancies in prescribing between
primary and secondary sectors of mental health service pro-
vision.  Psychiatric Bull 2002, 26:371-374.
38. Sagripanti M, Dean B, Barber N: An evaluation of the process-
related medication risks for elective surgery patients from
pre-operative assessment to discharge.  Int J Pharmacy Practice
2002, 10:161-170.
39. Franklin BD, O'Grady K, Donyai P, Jacklin A, Barber N: The impact
of a closed-loop prescribing and administration system on
prescribing errors, administration errors and staff time.  Qual
Safe Health Care 2007, 16:279-284.
40. Donyai P, O'Grady K, Jacklin A, Barber N, Franklin BD: The effects
of electronic prescribing on the quality of prescribing.  Br J Clin
Pharmacol 2007, 65:230-237.
41. Barber N, Franklin BD, Cornford T, Klecun E, Savage I: Safer, faster,
better? Evaluating electronic prescribing. Report to the Patient Safety
Research Programme London: The Department of Health; 2006. 
42. Tully MP, Parker D, Buchan I, McElduff P, Heathfield H, Rogers J,
Healthfield s, Latif S, Smith G, Eden M, Malik H, Cantrill J: Patient Safety
Research Programme Medication Errors 2: Pilot Study Volume 16. London:
The Department of Health; 2007:40-44. 
43. Gethins B: Wise up to medication errors.  Pharmacy in Practice
1996, 6:323-328.
44. Olsen S, Neale G, Schwab K, Psalia B, Patel T, Chapman EJ, Vincent
C: Hospital staff should use more than one method to detect
adverse events and potential adverse events: incident
reporting, pharmacist surveillance and local real-time
review may all have a place.  Qual Safe Health Care 2007,
16:40-44.
45. Duggan C, Bates I, Hough J: Discrepancies in prescribing. Where
do they occur?  Pharmaceutical J 1996, 256:65-67.
46. Duggan C, Feldman R, Hough J, Bates I: Reducing adverse pre-
scribing discrepancies following hospital discharge.  Int J Phar-
macy Practice 1998, 6:77-82.
47. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn
H:  An investigation of hospital generated pharmaceutical
care when patients are discharged from hospital.  Br J Clin Phar-
macol 1997, 44:163-165.
48. Hassey A, Gerrett D, Wilson A: A survey of validity and utility of
electronic patient records in a general practice.  Br Med J 2001,
322:1401-1405.
49. Jordon K, Porcheret M, Croft P: Quality of morbidity coding in
general practice computerized medical records: a system-
atic review.  Fam Pract 2004, 21:396-412.
50. Natarajan R: Transferring best practices to healthcare: oppor-
tunities and challenges.  TQM Magazine 2006, 18:572-582.
51. Slack N, Chambers S, Johnston R, Betts A: Operations and Process Man-
agement New Jersey: Prentice Hall; 2006. 
52. Benneyan JC, Lloyd RC, Plsek PE: Statistical process control as a
tool for research and healthcare improvement.  Qual Safe
Health Care 2003, 12:458-464.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1741-7015/7/50/prepub